These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14190550)

  • 1. END-PRODUCT INHIBITION OF THYMIDINE KINASE ACTIVITY IN NORMAL AND LEUKEMIC HUMAN LEUKOCYTES.
    BRESNICK E; KARJALA RJ
    Cancer Res; 1964 Jun; 24():841-6. PubMed ID: 14190550
    [No Abstract]   [Full Text] [Related]  

  • 2. MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.
    DUBBS DR; KIT S
    Virology; 1964 Apr; 22():493-502. PubMed ID: 14166109
    [No Abstract]   [Full Text] [Related]  

  • 3. PHOSPHORYLATION OF THYMIDINE DIPHOSPHATE IN RESTING AND PROLIFERATING MAMMALIAN CELLS.
    BIANCHI PA; FARINA MV; POLLI E
    Biochim Biophys Acta; 1964 Oct; 91():323-5. PubMed ID: 14240650
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF D,L-GLYCERALDEHYDE AND ACROLEIN ON LEUKEMIC LEUKOCYTES OF THE EXPERIMENTAL HEMOBLASTOSES L 14 AKR AND LAH VUFB IN VITRO].
    MOTYCKA K; LACKO L
    Z Krebsforsch; 1965 Feb; 66():491-5. PubMed ID: 14263010
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymidine salvage pathway in normal and leukemic leukocytes with effects of ATP on enzyme control.
    Rabinowitz Y; Wilhite BA
    Blood; 1969 May; 33(5):759-71. PubMed ID: 4305274
    [No Abstract]   [Full Text] [Related]  

  • 6. CELLULAR ACCUMULATION OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE IN VITRO. II. STUDIES ON THE MECHANISM OF ACCUMULATION IN LEUKEMIC LEUKOCYTES.
    BLOCK JB; FIELD M; OLIVERIO VT
    Cancer Res; 1964 Dec; 24():1947-51. PubMed ID: 14247506
    [No Abstract]   [Full Text] [Related]  

  • 7. In search of a key.
    Roberts D
    Natl Cancer Inst Monogr; 1971 Dec; 34():118-30. PubMed ID: 4946577
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the effect of therapy on cells in the blood of leukemic patients capable of incorporating H3-thymidine.
    BOND VP; RUBINI JR; FLIEDNER TM; CRONKITE EP
    J Lab Clin Med; 1962 Mar; 59():412-8. PubMed ID: 13870927
    [No Abstract]   [Full Text] [Related]  

  • 9. DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.
    KIT S; DUBBS DR; PIEKARSKI LJ; HSU TC
    Exp Cell Res; 1963 Aug; 31():297-312. PubMed ID: 14056989
    [No Abstract]   [Full Text] [Related]  

  • 10. SOME FACTORS AFFECTING THE PHOSPHORYLATION OF THYMIDINE BY TRANSPLANTABLE RAT HEPATOMAS.
    BUKOVSKY J; ROTH JS
    Cancer Res; 1965 Apr; 25():358-64. PubMed ID: 14281100
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme activities and deoxynucleoside utilization of leukemic leukocytes in relation to drug therapy and resistance.
    Roberts D; Hall TC
    Cancer Res; 1969 Jan; 29(1):166-73. PubMed ID: 5249740
    [No Abstract]   [Full Text] [Related]  

  • 12. ACID-SOLUBLE NUCLEOTIDES IN LEUKEMIC CELLS.
    NAKAI GS; CRADDOCK CG
    Cancer Res; 1965 May; 25():575-8. PubMed ID: 14297496
    [No Abstract]   [Full Text] [Related]  

  • 13. MITOTIC ABILITY OF LEUKEMIC LEUKOCYTES IN CHRONIC MYELOCYTIC LEUKEMIA.
    SANDBERG AA; KIKUCHI Y; CROSSWHITE LH
    Cancer Res; 1964 Sep; 24():1468-73. PubMed ID: 14221804
    [No Abstract]   [Full Text] [Related]  

  • 14. UPTAKE OF TRITITATED THYMIDINE BY LEUKEMIC CELLS: EFFECT OF VARIOUS LEUKOCYTE PREPARATIONS.
    PERRY S; MARSH JC
    Proc Soc Exp Biol Med; 1964 Jan; 115():51-4. PubMed ID: 14117468
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemistry of normal and leukemic white blood cells].
    Wilmanns W
    Z Klin Chem Klin Biochem; 1967 Sep; 5(5):233-41. PubMed ID: 4318734
    [No Abstract]   [Full Text] [Related]  

  • 16. THE BOVINE LEUKOCYTE--LEUKOKINETIC STUDIES IN NORMAL, LEUKEMIC, AND MASTITIC COWS.
    KANEKO JJ; NAKAJIMA H; SCHALM OW
    Am J Vet Res; 1964 Jan; 25():97-102. PubMed ID: 14103255
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrimidine metabolism in human leukocytes. I. Contribution of exogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukemic leukocytes.
    Cooper RA; Perry S; Breitman TR
    Cancer Res; 1966 Nov; 26(11):2267-75. PubMed ID: 5225414
    [No Abstract]   [Full Text] [Related]  

  • 18. CELLULAR ACCUMULATION OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE IN VITRO. I. GENERAL CHARACTERISTICS OF CELLULAR UPTAKE.
    FIELD M; BLOCK JB; OLIVERIO VT; RALL DP
    Cancer Res; 1964 Dec; 24():1939-46. PubMed ID: 14247505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease].
    Filanovskaia LI; Togo AV; Shcherbakova EG; Blinov MN
    Vopr Med Khim; 1994; 40(1):29-32. PubMed ID: 8122406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thymidine kinase activity: a biochemical strategy to enhance the activation of antineoplastic drugs.
    Vázquez-Padua MA
    P R Health Sci J; 1994 Mar; 13(1):19-23. PubMed ID: 8016290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.